Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
HQY	HEALTHEQUITY INC	$7.46B	11.40%	7.10%	11.59%	30.80%	0.64	2.99	71.20%	17.40%	26.52%
ABBV	ABBVIE INC	$484.83B	-135.70%	4.70%	12.13%	16.40%	-23.58	0.81	71.50%	9.80%	17.61%
GDRX	GOODRX HOLDINGS INC	$1.18B	2.60%	0.90%	6.94%	10.20%	2.62	1.38	90.80%	2.10%	10.47%
BRKR	BRUKER CORP	$8.56B	-4.40%	-1.70%	-0.06%	-0.10%	1.52	1.85	46.40%	-3.10%	-0.08%
MDT	MEDTRONIC PLC	$118.97B	10.60%	5.70%	8.94%	13.10%	0.85	2.07	65.00%	13.90%	19.41%
EW	EDWARDS LIFESCIENCES CORP	$49.15B	9.70%	7.40%	11.85%	21.30%	0.30	4.52	77.80%	15.40%	22.49%
WST	WEST PHARMACEUTICAL SERVICES INC	$26.17B	18.50%	13.60%	20.77%	23.10%	0.36	2.82	36.80%	17.00%	21.45%
JYNT	JOINT CORP	$98.65M	22.00%	6.30%	13.86%	53.60%	2.26	1.83	81.80%	6.50%	6.55%
PHR	PHREESIA INC	$667.26M	3.00%	1.70%	2.73%	7.80%	0.74	1.76	67.50%	2.10%	2.71%
UNH	UNITEDHEALTH GROUP INC	$339.08B	14.60%	4.50%	10.38%	17.60%	2.07	0.78	19.50%	3.10%	4.56%
PNTG	PENNANT GROUP INC	$1.40B	9.50%	3.50%	6.46%	7.10%	1.76	1.21	13.80%	2.90%	5.19%
ELAN	ELANCO ANIMAL HEALTH INC	$11.20B	-3.00%	-1.50%	0.70%	1.10%	1.06	2.05	55.40%	-4.00%	1.63%
OMDA	OMADA HEALTH INC	$1.12B	1.80%	1.40%	1.86%	104.50%	0.30	3.91	68.20%	1.40%	1.52%
PAHC	PHIBRO ANIMAL HEALTH CORP	$1.49B	28.70%	7.00%	15.34%	10.50%	2.90	2.96	33.80%	6.60%	11.97%
ORMP	ORAMED PHARMACEUTICALS INC	$173.46M	73.00%	64.20%	32.47%	50.70%	0.16	4.98	N/A	N/A	N/A
FTRE	FORTREA HOLDINGS INC	$1.99B	-15.50%	-3.10%	0.37%	0.50%	4.18	0.96	19.30%	-3.20%	0.24%
LMRI	LUMEXA IMAGING HOLDINGS INC	$1.02B	N/A	N/A	N/A	N/A	1.94	1.44	N/A	N/A	N/A
NUTX	NUTEX HEALTH INC	$1.40B	51.90%	18.90%	31.94%	29.60%	1.16	5.00	51.30%	21.20%	31.97%
SOLV	SOLVENTUM CORP	$14.69B	29.00%	10.10%	18.53%	27.20%	1.97	1.02	54.70%	17.30%	23.60%
ILMN	ILLUMINA INC	$40.95B	31.10%	12.70%	21.94%	24.00%	1.34	1.80	66.40%	18.40%	24.77%
VEEV	VEEVA SYSTEMS INC	$48.84B	14.00%	11.50%	17.46%	25.10%	0.22	5.46	75.00%	29.30%	38.38%
KRMD	KORU MEDICAL SYSTEMS INC	$138.52M	-10.60%	-6.50%	-8.71%	-13.00%	0.55	2.72	62.40%	-4.00%	-4.01%
SNN	SMITH & NEPHEW PLC	$12.23B	11.70%	5.80%	10.25%	11.90%	1.13	2.14	68.00%	10.10%	14.91%
GKOS	GLAUKOS CORP	$9.76B	-27.10%	-20.30%	-22.97%	-31.50%	0.35	5.04	60.70%	-30.70%	-30.67%
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.86B	-426.30%	-4.40%	4.99%	3.70%	-43.32	1.45	86.60%	-5.10%	3.31%
ARGX	ARGENX SE	$50.20B	23.60%	19.90%	20.69%	41.10%	0.19	5.12	90.10%	32.20%	32.85%
RLYB	RALLYBIO CORP	$88.79M	68.60%	64.50%	49.61%	272.20%	0.04	27.27	100.00%	7,051.20%	7,256.19%
ENSG	ENSIGN GROUP INC	$10.10B	16.50%	6.90%	10.41%	8.00%	1.35	1.21	16.00%	6.90%	9.23%
ANL	ADLAI NORTYE GROUP LTD	$756.24M	-20.20%	-14.10%	-9.53%	-39.60%	0.16	9.55	100.00%	-124.80%	-117.79%
CERS	CERUS CORP	$455.45M	-10.30%	-3.10%	1.07%	0.70%	1.92	1.83	57.20%	-2.70%	0.51%
CSTL	CASTLE BIOSCIENCES INC	$1.00B	-4.20%	-3.50%	-3.73%	-5.20%	0.19	6.04	77.30%	-5.40%	-5.27%
DHR	DANAHER CORP	$156.65B	7.70%	4.70%	6.01%	16.40%	0.76	1.65	58.50%	15.90%	20.19%
WAT	WATERS CORP	$42.17B	1.90%	1.10%	1.58%	5.90%	0.63	1.86	50.90%	3.60%	7.63%
ALGN	ALIGN TECHNOLOGY INC	$10.20B	10.10%	6.60%	12.62%	20.30%	0.52	1.40	68.00%	10.00%	13.74%
MCK	MCKESSON CORP	$112.15B	-194.40%	5.40%	33.52%	91.30%	-21.74	0.89	3.60%	1.10%	1.47%
A	AGILENT TECHNOLOGIES INC	$48.38B	20.50%	11.00%	15.11%	23.80%	0.90	2.05	53.80%	19.50%	23.93%
STAA	STAAR SURGICAL CO	$1.08B	1.10%	0.80%	4.33%	6.90%	0.30	4.67	76.60%	1.10%	5.12%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$1.70B	-35.40%	-12.20%	-9.52%	-10.20%	1.21	4.05	34.90%	-37.10%	-25.79%
NRC	NRC HEALTH	$446.15M	48.50%	4.30%	14.62%	13.60%	19.79	0.65	61.70%	4.20%	10.56%
PLX	PROTALIX BIOTHERAPEUTICS INC	$221.57M	31.60%	20.10%	31.31%	48.10%	0.55	2.94	69.20%	23.50%	30.66%
PODD	INSULET CORP	$9.58B	26.70%	12.10%	22.86%	21.40%	1.23	2.49	71.10%	12.30%	18.12%
INCY	INCYTE CORP	$22.02B	29.60%	22.60%	30.02%	87.80%	0.24	4.59	92.60%	27.70%	33.85%
AMN	AMN HEALTHCARE SERVICES INC	$1.42B	15.30%	4.60%	12.54%	19.70%	2.19	1.13	27.80%	3.10%	5.82%
ATEC	ALPHATEC HOLDINGS INC	$1.67B	-6,752.20%	-13.90%	-11.08%	-7.20%	-66.54	1.89	70.80%	-13.50%	-7.52%
AMGN	AMGEN INC	$223.19B	89.30%	9.50%	18.47%	18.00%	7.18	1.37	69.50%	23.00%	34.01%
ASTH	ASTRANA HEALTH INC	$2.11B	5.10%	1.80%	8.39%	12.10%	2.03	1.23	10.50%	1.10%	3.35%
IRTC	IRHYTHM HOLDINGS INC	$3.55B	-9.00%	-1.40%	0.02%	0.00%	4.88	3.86	71.50%	-1.70%	0.03%
HTFL	HEARTFLOW INC	$4.38B	-42.30%	-33.50%	-38.29%	-48.00%	0.23	5.08	80.10%	-55.80%	-54.23%
DVA	DAVITA INC	$11.62B	-123.60%	4.80%	11.75%	9.10%	-21.74	1.47	32.40%	6.00%	12.46%
AXGN	AXOGEN INC	$1.94B	-17.90%	-13.00%	-10.70%	-14.20%	0.19	6.60	74.60%	-13.40%	-11.70%
SYK	STRYKER CORP	$108.38B	16.40%	7.90%	14.65%	22.10%	1.00	2.16	65.00%	14.40%	23.39%
NVCR	NOVOCURE LTD	$1.67B	-44.00%	-15.90%	-26.88%	-19.50%	1.35	2.89	76.10%	-21.20%	-22.08%
BAX	BAXTER INTERNATIONAL INC	$12.87B	-16.60%	-5.30%	-2.05%	-2.20%	2.19	1.95	30.10%	-9.30%	-2.89%
HOWL	WEREWOLF THERAPEUTICS INC	$48.16M	-167.00%	-59.90%	-184.51%	-237.20%	0.48	2.91	100.00%	-164.80%	-143.14%
NBIX	NEUROCRINE BIOSCIENCES INC	$13.74B	21.10%	14.70%	21.03%	28.30%	0.45	1.87	98.00%	20.90%	27.95%
ELV	ELEVANCE HEALTH INC	$92.23B	11.20%	4.00%	8.90%	11.40%	1.81	1.52	15.10%	2.50%	3.64%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$6.57B	-40.50%	-31.60%	-36.33%	-73.20%	0.24	4.35	48.40%	-89.10%	-90.40%
SIBN	SI-BONE INC	$882.03M	-8.20%	-6.10%	-5.40%	-5.50%	0.36	9.15	79.50%	-6.90%	-5.68%
HCAT	HEALTH CATALYST INC	$130.95M	-129.70%	-56.90%	-92.45%	-94.40%	2.56	2.70	50.50%	-90.60%	-84.36%
VIR	VIR BIOTECHNOLOGY INC	$1.80B	-30.00%	-23.60%	-22.44%	-31.30%	0.24	6.04	100.00%	-83.00%	-82.87%
MRK	MERCK & CO INC	$350.29B	6.60%	2.40%	7.54%	8.00%	2.09	1.32	73.00%	4.80%	11.56%
MTD	METTLER TOLEDO INTERNATIONAL INC	$32.02B	-1,199.90%	24.90%	47.23%	32.70%	285.28	1.12	60.30%	21.90%	28.22%
VRTX	VERTEX PHARMACEUTICALS INC	$122.98B	23.30%	16.90%	22.49%	31.00%	0.35	3.19	86.00%	35.00%	41.96%
ISRG	INTUITIVE SURGICAL INC	$149.10B	17.80%	15.50%	19.98%	26.90%	0.14	4.96	66.70%	28.40%	34.32%
CRON	CRONOS GROUP INC	$1.18B	6.50%	5.90%	1.80%	5.90%	0.06	16.18	45.90%	39.10%	11.32%
ACAD	ACADIA PHARMACEUTICALS INC	$3.21B	32.40%	24.40%	8.79%	13.60%	0.33	3.39	91.10%	33.40%	10.66%
ENOV	ENOVIS CORP	$1.10B	-68.20%	-27.80%	-32.89%	-39.00%	1.55	1.99	61.10%	-48.00%	-45.17%
QDEL	QUIDELORTHO CORP	$966.91M	-55.30%	-18.40%	-17.52%	-16.80%	2.22	1.39	44.60%	-39.20%	-30.93%
BIIB	BIOGEN INC	$33.82B	4.50%	2.80%	3.59%	7.30%	0.70	1.87	74.00%	8.30%	10.09%
MGTX	MEIRAGTX HOLDINGS PLC	$954.67M	283.90%	29.40%	27.73%	59.10%	0.84	3.76	97.90%	19.90%	23.60%
CRL	CHARLES RIVER LABORATORIES INTERNATIONAL INC	$14.27B	-7.70%	-3.20%	-1.24%	-1.40%	1.64	1.35	32.70%	-6.00%	-1.99%
BFRI	BIOFRONTERA INC	$13.25M	-127.80%	-27.40%	-43.28%	-52.50%	3.04	1.18	79.30%	-13.80%	-12.68%
COO	COOPER COMPANIES INC	$10.38B	6.90%	4.60%	5.10%	7.00%	0.52	1.22	65.90%	13.50%	13.02%
HLN	HALEON PLC	$42.26B	N/A	N/A	N/A	N/A	0.99	0.69	N/A	N/A	N/A
RVTY	REVVITY INC	$17.30B	3.30%	2.00%	3.33%	8.30%	0.67	1.80	55.00%	8.20%	12.33%
HNGE	HINGE HEALTH INC	$8.48B	51.00%	14.00%	32.07%	160.20%	1.40	1.34	84.50%	14.90%	15.41%
PFE	PFIZER INC	$161.70B	4.90%	2.10%	2.47%	3.70%	1.36	1.27	73.20%	6.80%	6.55%
EHC	ENCOMPASS HEALTH CORP	$12.27B	25.00%	8.60%	14.53%	13.00%	1.54	1.19	27.50%	10.00%	15.42%
AMWL	AMERICAN WELL CORP	$207.00M	-33.30%	-23.40%	-32.74%	18,566.30%	0.42	2.90	51.90%	-35.70%	-35.34%
EBS	EMERGENT BIOSOLUTIONS INC	$354.30M	-35.90%	-13.60%	-9.57%	-8.10%	2.27	5.42	55.90%	-23.00%	-12.35%
GRDN	GUARDIAN PHARMACY SERVICES INC	$2.52B	30.80%	15.80%	33.10%	72.00%	0.76	1.65	21.60%	4.50%	6.55%
APMD	APNIMED INC	$742.28M	N/A	N/A	N/A	N/A	-0.71	5.19	N/A	N/A	N/A
IDXX	IDEXX LABORATORIES INC	$40.99B	72.00%	33.60%	67.86%	59.10%	1.14	1.17	62.40%	25.00%	32.11%
EMBC	EMBECTA CORP	$351.29M	-14.00%	7.90%	26.22%	11.10%	-3.07	1.68	59.00%	8.60%	21.76%
OABI	OMNIAB INC	$683.33M	-16.60%	-14.80%	-16.53%	-64.50%	0.12	4.80	98.30%	-115.10%	-118.86%
ANGO	ANGIODYNAMICS INC	$458.39M	-19.20%	-12.70%	-17.76%	-38.30%	0.48	2.40	55.70%	-10.10%	-9.95%
LQDA	LIQUIDIA CORP	$2.40B	149.60%	36.30%	52.95%	86.10%	1.68	2.31	92.50%	30.70%	39.06%
ADMA	ADMA BIOLOGICS INC	$2.31B	39.60%	26.60%	37.03%	38.00%	0.68	6.97	64.70%	33.00%	43.98%
BIO	BIO-RAD LABORATORIES INC	$9.73B	3.20%	2.20%	4.30%	4.20%	0.43	3.14	51.90%	8.60%	15.42%
HUM	HUMANA INC	$50.48B	6.90%	2.40%	6.67%	7.20%	1.97	1.74	13.70%	0.90%	1.57%
IART	INTEGRA LIFESCIENCES HOLDINGS CORP	$1.08B	-0.70%	-0.20%	2.84%	2.80%	2.42	3.60	52.50%	-0.40%	5.56%
SNY	SANOFI	$95.41B	5.70%	3.10%	6.00%	13.20%	0.86	0.99	72.80%	8.10%	11.91%
GEHC	GE HEALTHCARE TECHNOLOGIES INC	$31.07B	18.90%	5.40%	10.44%	15.90%	2.37	1.26	39.50%	9.30%	14.21%
AZTA	AZENTA INC	$1.66B	-7.60%	-6.20%	-10.19%	-20.70%	0.24	2.50	43.40%	-20.00%	-26.62%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$2.30B	9.20%	4.60%	6.35%	16.30%	1.38	3.23	53.50%	15.60%	25.37%
FMS	FRESENIUS MEDICAL CARE AG	$11.22B	7.20%	3.00%	6.78%	7.70%	1.42	1.07	26.40%	4.80%	8.42%
HCA	HCA HEALTHCARE INC	$99.75B	-112.60%	11.20%	24.32%	13.80%	-10.01	0.99	42.60%	8.80%	14.32%
SLN	SILENCE THERAPEUTICS PLC	$418.66M	N/A	-48.00%	-63.98%	-103.30%	-1.77	7.42	85.90%	-9,748.50%	-9,748.13%
STLN	STARLING ONCOLOGY INC	$682.84M	N/A	-24.20%	-39.86%	-23.00%	-8.15	1.36	15.70%	-7.00%	-5.65%
ARVN	ARVINAS INC	$447.24M	1.90%	1.30%	1.70%	2.00%	0.20	7.91	97.20%	2.90%	3.19%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	605	-3.31%	-4.41%	-12.70%	-72.42%	14.11x	4.88x	-11.01%	-10.03%	-8.07%	+80.04%	Strong Buy
Diagnostics & Research	50	+0.10%	+0.57%	+9.91%	+27.17%	11.79x	4.71x	-29.33%	+5.36%	+11.40%	+2.64%	Buy
Drug Manufacturers - General	20	-1.75%	+0.62%	+1.14%	+24.37%	39.28x	7.83x	+23.62%	+10.74%	+19.12%	+25.37%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.97%	-0.73%	-5.30%	-94.19%	-1.74x	2.35x	-1.68%	+1.60%	+7.12%	+194.41%	Buy
Healthcare Plans	10	-0.24%	+3.91%	-0.88%	+18.01%	55.82x	2.32x	+10.70%	+3.28%	+8.15%	+11.54%	Buy
Health Information Services	50	-0.34%	-0.87%	+0.40%	-44.85%	11.95x	4.03x	+7.12%	+4.01%	+9.09%	+17.05%	Buy
Medical Care Facilities	48	-0.09%	+1.43%	-0.27%	-53.67%	16.80x	5.73x	-42.74%	+7.27%	+14.52%	+13.50%	Buy
Medical Devices	132	-0.38%	+0.33%	-1.59%	-95.34%	22.66x	3.06x	-9.45%	+5.29%	+9.68%	+27.22%	Strong Buy
Medical Distribution	8	+0.84%	+3.87%	+3.55%	+23.59%	26.62x	-190.64x	-76.01%	+4.11%	+24.39%	+6.81%	Buy
Medical Instruments & Supplies	50	-0.46%	+1.98%	+2.84%	+3.00%	44.54x	3.37x	+8.63%	+7.24%	+11.01%	+14.77%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Oct 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: A, Sentiment: C, Safety: C, Financials: A, and AI: B.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 91.3% over the past year, overperforming other healthcare stocks by 169 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -40.71% from Puma Biotechnology's current stock price of $10.12.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the #2 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bausch Health Companies (NYSE:BHC) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Bausch Health Companies (NYSE:BHC) has a Due Diligence Score of 6, which is -21 points lower than the healthcare sector average of 27. Although this number is below the industry average, our proven quant model rates BHC as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Bausch Health Companies has seen its stock lose -3.6% over the past year, overperforming other healthcare stocks by 74 percentage points.

Bausch Health Companies has an average 1 year price target of $9.00, an upside of 52.8% from Bausch Health Companies's current stock price of $5.89.

Bausch Health Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Bausch Health Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #3 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 106.39% over the past year, overperforming other healthcare stocks by 184 percentage points.

Bioventus has an average 1 year price target of $16.00, an upside of 17.99% from Bioventus's current stock price of $13.56.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 79 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Conmed (NYSE:CNMD)

Conmed (NYSE:CNMD) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.25%. Conmed's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Conmed's dividend has not shown consistent growth over the last 10 years.

Conmed's dividend payout ratio of 10.8% indicates that its dividend yield is sustainable for the long-term.

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 20.92%, which is 19 percentage points higher than the healthcare sector average of 2.25%.

Cumberland Pharmaceuticals's dividend payout ratio of -411% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.52%, which is 9 percentage points higher than the healthcare sector average of 2.25%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 207.9% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.35% in the last day, and down -0.79% over the last week. Syndax Pharmaceuticals was the among the top losers in the healthcare sector, dropping -15.71% yesterday.

Syndax Pharmaceuticals shares are trading lower after the company announced that the MAXPIRe Phase 2 trial of axatilimab in idiopathic pulmonary fibrosis did not meet its primary endpoint of the annualized rate of decline in forced vital capacity.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 142.57% in the past year. It has overperformed other stocks in the healthcare sector by 220 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 55.68% in the past year. It has overperformed other stocks in the healthcare sector by 133 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -53.56% in the past year. It has overperformed other stocks in the healthcare sector by 24 percentage points.

Are healthcare stocks a good buy now?

59.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.26% over the next year.

4.04% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.26% of healthcare stocks are rated B (Buy), 48.61% are rated C (Hold), 27.4% are rated D (Sell), and 6.69% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 30.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.